Emergency War Surgery NATO Handbook: Part I: Types of Wounds and Injuries: Chapter
VI: Chemical Injury
Choking Agents
United States Department of Defense
This group, so called because of the pronounced irritation of the upper as well as the
lower respiratory tract, consists of phosgene (CG). diphosgene (DP), and chlorine (CL).
Phosgene gas, approximately three times heavier than air, hugs the ground as a white cloud
that spills into bunkers and fighting pits.
The choking agents are treacherous in that the onset of fulminating pulmonary edema is
delayed several hours following exposure. Thus, a soldier with dyspnea and mild substernal
discomfort may have normal auscultatory and radiographic signs and be returned to duty,
only to progress to extremis a few hours later.
It is imperative that any casualty with known phosgene exposure, no matter how minor
his dyspnea or upper respiratory irritation, be observed for 4-6 hours at the very least,
then carefully checked for impending pulmonary edema before being returned to duty (see
below).
Diagnosis: Phosgene has the characteristic odor of freshly mown grass. The threshold
for detecting phosgene's characteristic odor is so close to the irritant threshold as to
be useless as a warning. The individual's sense of dyspnea as the lung stiffens still
serves as the best indicator of impending pulmonary edema.
Irritant effects on the eyes and tracheo-bronchial tree - accompanied by tearing,
cough, or chest discomfort - and dyspnea or tachypnea are the first effects noted. These
symptoms may appear to be rather minor at first, resembling the symptoms of a common cold
or anxiety reaction. From one half hour to four or six (rarely twelve) hours following
exposure, cough, chest pain, cyanosis, and progressive dyspnea herald impending overt
pulmonary edema. Painful cough, frothy sputum, cyanosis, rales, dullness to percussion,
and radiographic evidence support the diagnosis.
Uncomplicated cases recover without permanent after effects. However, the possibility
of secondary bacterial pulmonary infection is considerable. Circulatory failure or the
patient appearing "mouse-grey cyanotic" are ominous signs. The "plum-blue
cyanotic" patient, conversely, has a good chance to survive. These gross observations
may be helpful in mass casualty triage.
Treatment: Recall the treacherous "silent period" that follows the inhalation
of a pulmonary irritant. Observe the symptom-free patient with known exposure to a choking
agent for at least 4-6 hours and the casualty with known exposure and minimal symptoms
(itching eyes, runny nose, mild cough, vague chest discomfort) for at least 12 hours. In
either case, do not release these personnel to duty without a careful re-examination of
the chest.
Treatment of non cardiac pulmonary edema in the field is mostly supportive, with
enforced rest to minimize exertion. Oxygen with air admixed to 40% is sufficient and will
help conserve limited supplies. Intravenous fluids (as in any case of pulmonary edema)
should be administered sparingly. The risk of bronchopneumonia is greatest when pulmonary
edema begins to subside. The clinician must be alert for changes in sputum color or a
sudden rise in body temperature.
According to current thinking, (a) prophylactic antibiotics are of no proven benefit,
(b) steroids, whether given intravenously or by inhalation, appear to offer no advantage,
(c) early positive end-expiratory pressure (PEEP) breathing may well reduce the severity
of the subsequent pulmonary edema, and (d) patients in severe distress will require
endotracheal intubation or tracheostomy and positive pressure mechanical ventilation.
Phosphorus pentoxide, the dense white smoke associated with white phosphorus munitions,
presents the same clinical picture as phosgene exposure. Experience has shown that the
chemical burn of the alveolus produced by phosphorus pentoxide is irreversible and fatal
in those who progress to pulmonary edema. It is a sobering and frustrating experience to
observe a totally asymptomatic soldier, exposed to phosphorus pentoxide inhalation,
progress from the asymptomatic state to intractable pulmonary edema and death over the
span of eight hours in spite of every supportive effort.
Approved for public release; Distribution is unlimited.
The listing of any non-Federal product in this CD is not an
endorsement of the product itself, but simply an acknowledgement of the source.
Operational Medicine 2001
Health Care in Military Settings
Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300 |
Operational Medicine
Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
January 1, 2001 |
United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323 |
This web version is provided by
The Brookside Associates Medical
Education Division. It contains original contents from the official US
Navy NAVMED P-5139, but has been reformatted for web access and includes
advertising and links that were not present in the original version. This web
version has not been approved by the Department of the Navy or the Department of
Defense. The presence of any advertising on these pages does not constitute an
endorsement of that product or service by either the US Department of Defense or
the Brookside Associates. The Brookside Associates is a private organization,
not affiliated with the United States Department of Defense.
Contact Us · ·
Other Brookside Products
|